NPR is a good source for news on the progress of psychedelics for some mental health concerns. Early June 2024 saw the advisors for the FDA reject use of MDMA (Ecstasy) as a treatment for Post-Traumatic Stress Disorder (PTSD). MDMA has been seen to show great promise to the Veteran community as a treatment for PTSD. It should be noted, although not likely, that the FDA may still approve MDMA at some level for the treatment of PTSD.
Concerns that lead to the rejection by the advisory centered around the methods and data bias they found in the study.
Read more detail regarding the state of approval (or lack thereof) of MDMA by the FDA here:
Will MDMA’s FDA setback derail psychedelic drug research? : Shots – Health News : NPR
